Cargando…

Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004

BACKGROUND: The lifelong exposure of the population to acrylamide has raised concerns about the possible health effects of the chemical. Data on the extent of exposure to acrylamide and its primary metabolite, glycidamide, are needed to aid in the assessment of potential health effects. OBJECTIVES:...

Descripción completa

Detalles Bibliográficos
Autores principales: Vesper, Hubert W., Caudill, Samuel P., Osterloh, John D., Meyers, Tunde, Scott, Deanna, Myers, Gary L.
Formato: Texto
Lenguaje:English
Publicado: National Institute of Environmental Health Sciences 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831930/
https://www.ncbi.nlm.nih.gov/pubmed/20123601
http://dx.doi.org/10.1289/ehp.0901021
_version_ 1782178293377662976
author Vesper, Hubert W.
Caudill, Samuel P.
Osterloh, John D.
Meyers, Tunde
Scott, Deanna
Myers, Gary L.
author_facet Vesper, Hubert W.
Caudill, Samuel P.
Osterloh, John D.
Meyers, Tunde
Scott, Deanna
Myers, Gary L.
author_sort Vesper, Hubert W.
collection PubMed
description BACKGROUND: The lifelong exposure of the population to acrylamide has raised concerns about the possible health effects of the chemical. Data on the extent of exposure to acrylamide and its primary metabolite, glycidamide, are needed to aid in the assessment of potential health effects. OBJECTIVES: The aim of this study was to assess human exposure to acrylamide and glycidamide in the general U.S. population through the measurement of hemoglobin adducts of acrylamide (HbAA) and glycidamide (HbGA). METHODS: HbAA and HbGA were measured in 7,166 subjects from the National Health and Nutrition Examination Survey. Stratified HbAA and HbGA data were reported by sex, age groups, race/ethnicity (Mexican American, non-Hispanic black, non-Hispanic white), and smoking status based on serum cotinine levels. Covariate-adjusted geometric means for each demographic group were calculated using multiple regression analysis. RESULTS: HbAA and HbGA levels ranged from 3 to 910 and from 4 to 756 pmol/g hemoglobin, respectively, with smokers having the highest levels overall. Tobacco smoke exposure in nonsmokers had a small but significant effect on HbAA and HbGA levels. Adjusted geometric mean levels for children 3–11 years of age were higher than for adults ≥ 60 years of age [mean (95% confidence interval): HbAA, 54.5 (49.1–51.5) and HbGA, 73.9 (71.3–76.6) vs. HbAA, 46.2 (44.3–48.2) and HbGA, 41.8 (38.7–45.2)]. Levels were highest in Mexican Americans [HbAA: 54.8 (51.9–57.8), HbGA: 57.9 (53.7–62.5)], whereas non-Hispanic blacks had the lowest HbGA levels [43.5 (41.1–45.9)]. CONCLUSIONS: U.S. population levels of acrylamide and glycidamide adducts are described. The high variability among individuals but modest differences between population subgroups suggest that sex, age, and race/ethnicity do not strongly affect acrylamide exposure. Adduct concentration data can be used to estimate relative exposure and to validate intake estimates.
format Text
id pubmed-2831930
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher National Institute of Environmental Health Sciences
record_format MEDLINE/PubMed
spelling pubmed-28319302010-03-17 Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004 Vesper, Hubert W. Caudill, Samuel P. Osterloh, John D. Meyers, Tunde Scott, Deanna Myers, Gary L. Environ Health Perspect Research BACKGROUND: The lifelong exposure of the population to acrylamide has raised concerns about the possible health effects of the chemical. Data on the extent of exposure to acrylamide and its primary metabolite, glycidamide, are needed to aid in the assessment of potential health effects. OBJECTIVES: The aim of this study was to assess human exposure to acrylamide and glycidamide in the general U.S. population through the measurement of hemoglobin adducts of acrylamide (HbAA) and glycidamide (HbGA). METHODS: HbAA and HbGA were measured in 7,166 subjects from the National Health and Nutrition Examination Survey. Stratified HbAA and HbGA data were reported by sex, age groups, race/ethnicity (Mexican American, non-Hispanic black, non-Hispanic white), and smoking status based on serum cotinine levels. Covariate-adjusted geometric means for each demographic group were calculated using multiple regression analysis. RESULTS: HbAA and HbGA levels ranged from 3 to 910 and from 4 to 756 pmol/g hemoglobin, respectively, with smokers having the highest levels overall. Tobacco smoke exposure in nonsmokers had a small but significant effect on HbAA and HbGA levels. Adjusted geometric mean levels for children 3–11 years of age were higher than for adults ≥ 60 years of age [mean (95% confidence interval): HbAA, 54.5 (49.1–51.5) and HbGA, 73.9 (71.3–76.6) vs. HbAA, 46.2 (44.3–48.2) and HbGA, 41.8 (38.7–45.2)]. Levels were highest in Mexican Americans [HbAA: 54.8 (51.9–57.8), HbGA: 57.9 (53.7–62.5)], whereas non-Hispanic blacks had the lowest HbGA levels [43.5 (41.1–45.9)]. CONCLUSIONS: U.S. population levels of acrylamide and glycidamide adducts are described. The high variability among individuals but modest differences between population subgroups suggest that sex, age, and race/ethnicity do not strongly affect acrylamide exposure. Adduct concentration data can be used to estimate relative exposure and to validate intake estimates. National Institute of Environmental Health Sciences 2010-02 2009-10-14 /pmc/articles/PMC2831930/ /pubmed/20123601 http://dx.doi.org/10.1289/ehp.0901021 Text en http://creativecommons.org/publicdomain/mark/1.0/ Publication of EHP lies in the public domain and is therefore without copyright. All text from EHP may be reprinted freely. Use of materials published in EHP should be acknowledged (for example, ?Reproduced with permission from Environmental Health Perspectives?); pertinent reference information should be provided for the article from which the material was reproduced. Articles from EHP, especially the News section, may contain photographs or illustrations copyrighted by other commercial organizations or individuals that may not be used without obtaining prior approval from the holder of the copyright.
spellingShingle Research
Vesper, Hubert W.
Caudill, Samuel P.
Osterloh, John D.
Meyers, Tunde
Scott, Deanna
Myers, Gary L.
Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004
title Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004
title_full Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004
title_fullStr Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004
title_full_unstemmed Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004
title_short Exposure of the U.S. Population to Acrylamide in the National Health and Nutrition Examination Survey 2003–2004
title_sort exposure of the u.s. population to acrylamide in the national health and nutrition examination survey 2003–2004
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831930/
https://www.ncbi.nlm.nih.gov/pubmed/20123601
http://dx.doi.org/10.1289/ehp.0901021
work_keys_str_mv AT vesperhubertw exposureoftheuspopulationtoacrylamideinthenationalhealthandnutritionexaminationsurvey20032004
AT caudillsamuelp exposureoftheuspopulationtoacrylamideinthenationalhealthandnutritionexaminationsurvey20032004
AT osterlohjohnd exposureoftheuspopulationtoacrylamideinthenationalhealthandnutritionexaminationsurvey20032004
AT meyerstunde exposureoftheuspopulationtoacrylamideinthenationalhealthandnutritionexaminationsurvey20032004
AT scottdeanna exposureoftheuspopulationtoacrylamideinthenationalhealthandnutritionexaminationsurvey20032004
AT myersgaryl exposureoftheuspopulationtoacrylamideinthenationalhealthandnutritionexaminationsurvey20032004